LT3754B - Method for preparating of pharmaceutical composition - Google Patents

Method for preparating of pharmaceutical composition Download PDF

Info

Publication number
LT3754B
LT3754B LTIP1660A LTIP1660A LT3754B LT 3754 B LT3754 B LT 3754B LT IP1660 A LTIP1660 A LT IP1660A LT IP1660 A LTIP1660 A LT IP1660A LT 3754 B LT3754 B LT 3754B
Authority
LT
Lithuania
Prior art keywords
tampon
gel
weight
pharmaceutical composition
mucosa
Prior art date
Application number
LTIP1660A
Other languages
English (en)
Lithuanian (lt)
Inventor
Jacques Julien Augros
Original Assignee
Sspl Sa Safe Sex Prod Licens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl Sa Safe Sex Prod Licens filed Critical Sspl Sa Safe Sex Prod Licens
Publication of LTIP1660A publication Critical patent/LTIP1660A/xx
Publication of LT3754B publication Critical patent/LT3754B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
LTIP1660A 1988-07-11 1993-12-22 Method for preparating of pharmaceutical composition LT3754B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (2)

Publication Number Publication Date
LTIP1660A LTIP1660A (en) 1995-07-25
LT3754B true LT3754B (en) 1996-03-25

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1660A LT3754B (en) 1988-07-11 1993-12-22 Method for preparating of pharmaceutical composition

Country Status (38)

Country Link
US (1) US5439685A (uk)
EP (1) EP0351301B1 (uk)
JP (1) JPH0774164B2 (uk)
KR (1) KR0143231B1 (uk)
CN (1) CN1035038C (uk)
AP (1) AP108A (uk)
AR (1) AR243381A1 (uk)
AT (1) ATE97570T1 (uk)
BR (1) BR8903523A (uk)
CA (1) CA1341304C (uk)
CZ (1) CZ280722B6 (uk)
DD (1) DD283932A5 (uk)
DE (1) DE68910892T2 (uk)
DK (1) DK173527B1 (uk)
ES (1) ES2062065T3 (uk)
FI (1) FI101595B (uk)
HK (1) HK131095A (uk)
HU (1) HU206634B (uk)
IE (1) IE63115B1 (uk)
IL (1) IL90910A (uk)
LT (1) LT3754B (uk)
LV (1) LV10573B (uk)
MA (1) MA22036A1 (uk)
MD (1) MD406C2 (uk)
MX (1) MX170801B (uk)
MY (1) MY106242A (uk)
NO (1) NO178843C (uk)
NZ (1) NZ229891A (uk)
OA (1) OA09123A (uk)
PL (1) PL161848B1 (uk)
PT (1) PT91108B (uk)
RU (1) RU2065742C1 (uk)
SK (1) SK423889A3 (uk)
TN (1) TNSN89074A1 (uk)
TR (1) TR28353A (uk)
UA (1) UA26124A (uk)
YU (1) YU47899B (uk)
ZA (1) ZA895263B (uk)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
CA2167537A1 (en) * 1993-07-19 1995-02-02 Tsuneo Ozeki Hepatitis c virus proliferation inhibitor
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
WO1998010744A1 (en) * 1996-09-12 1998-03-19 Simon Everard Barton Composition comprising an antiviral or antibacterial agent for preventing transmission of diseases
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
HU230315B1 (hu) * 2000-03-07 2016-01-28 Rush-Presbyterian-St. Luke's Medical Center Összetételek és eljárások patogén mikrobák és spermatozoák csapdázására
GB2412121B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Tampon with malodour counteractant
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
ATE289514T1 (de) * 2003-11-03 2005-03-15 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
CN101252942B (zh) * 2005-08-29 2010-12-22 赛普斯治疗有限责任公司 用于治疗或预防由革兰氏阳性细菌引起的病症的方法
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
AU2011325975B2 (en) 2010-11-12 2015-11-26 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
US8992893B2 (en) 2011-04-19 2015-03-31 Arms Pharmaceutical, Llc Method of inhibiting harmful microorganisms and barrier-forming composition therefor
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
DE102020131233A1 (de) * 2020-11-25 2022-05-25 Netzsch Trockenmahltechnik Gmbh Verfahren zur herstellung eines homogenisierten gemischs aus kohlenstoff, schwefel und ptfe
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113998A2 (en) 1982-12-22 1984-07-25 Herpes Pharmaceutical, Inc. Composition and treatment for herpes simplex viral infections
EP0285285A2 (en) 1987-03-17 1988-10-05 Public Health Laboratory Service Board Method and composition for the treatment and prevention of viral infections

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (uk) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
JPS58103453A (ja) * 1981-12-07 1983-06-20 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド １−置換イミダゾ−ルを放出する使い捨て膣内避妊具
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113998A2 (en) 1982-12-22 1984-07-25 Herpes Pharmaceutical, Inc. Composition and treatment for herpes simplex viral infections
EP0285285A2 (en) 1987-03-17 1988-10-05 Public Health Laboratory Service Board Method and composition for the treatment and prevention of viral infections

Also Published As

Publication number Publication date
NO178843C (no) 1996-06-19
IL90910A (en) 1994-12-29
NO892826L (no) 1990-01-12
MA22036A1 (fr) 1991-10-01
YU47899B (sh) 1996-05-20
CN1035038C (zh) 1997-06-04
LV10573A (lv) 1995-04-20
DE68910892D1 (de) 1994-01-05
YU135789A (en) 1992-05-28
DK340289A (da) 1990-01-12
RU2065742C1 (ru) 1996-08-27
MY106242A (en) 1995-04-29
CZ423889A3 (en) 1995-12-13
SK278614B6 (en) 1997-11-05
DK340289D0 (da) 1989-07-10
IE63115B1 (en) 1995-03-22
PL161848B1 (pl) 1993-08-31
UA26124A (uk) 1999-06-07
AU3802689A (en) 1990-01-11
KR0143231B1 (ko) 1998-07-15
TR28353A (tr) 1996-05-16
CA1341304C (fr) 2001-10-09
LTIP1660A (en) 1995-07-25
JPH02167235A (ja) 1990-06-27
MX170801B (es) 1993-09-14
BR8903523A (pt) 1991-11-05
SK423889A3 (en) 1997-11-05
PL280531A1 (en) 1990-05-28
FI893340A (fi) 1990-01-12
FI101595B1 (fi) 1998-07-31
EP0351301A2 (fr) 1990-01-17
US5439685A (en) 1995-08-08
IE892218L (en) 1990-01-11
IL90910A0 (en) 1990-02-09
NO178843B (no) 1996-03-11
HUT50445A (en) 1990-02-28
DK173527B1 (da) 2001-01-29
ES2062065T3 (es) 1994-12-16
ATE97570T1 (de) 1993-12-15
AP108A (en) 1991-02-23
HK131095A (en) 1995-08-24
KR900001366A (ko) 1990-02-27
MD406C2 (ro) 1996-06-30
PT91108A (pt) 1990-02-08
LV10573B (en) 1995-08-20
TNSN89074A1 (fr) 1991-02-04
CZ280722B6 (cs) 1996-04-17
NZ229891A (en) 1991-01-29
NO892826D0 (no) 1989-07-07
HU206634B (en) 1992-12-28
DD283932A5 (de) 1990-10-31
JPH0774164B2 (ja) 1995-08-09
AP8900133A0 (en) 1989-10-31
AR243381A1 (es) 1993-08-31
AU625716B2 (en) 1992-07-16
OA09123A (fr) 1991-10-31
DE68910892T2 (de) 1994-05-05
PT91108B (pt) 1995-01-31
CN1041879A (zh) 1990-05-09
EP0351301A3 (en) 1990-12-19
ZA895263B (en) 1991-03-27
FI893340A0 (fi) 1989-07-10
EP0351301B1 (fr) 1993-11-24
FI101595B (fi) 1998-07-31

Similar Documents

Publication Publication Date Title
LT3754B (en) Method for preparating of pharmaceutical composition
US6328991B1 (en) Composition and method for prevention of sexually transmitted diseases, including aids
US5527534A (en) Vaginal sponge delivery system
Amaral et al. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel
WO1994008536A9 (en) Vaginal sponge delivery system
EP0727988B1 (en) Aids prophylactic lubricating composition and devices for its use
DK0784467T3 (da) Enhedsdosisform til vaginal administrering anvendeligt som lokalt svangerskabsforebyggende middel og/eller til bekæmpelse a
KR20120099473A (ko) Ｈｉｖ 감염 예방을 위한 히드록시타이로졸 및 유도체의 국소적 사용
Omar et al. The future of microbicides
Creatsas et al. Safety and tolerability of the new contraceptive sponge Protectaid®
HRP921074A2 (en) A process for the production of a preparation for preventing sexual deseases from spreading
Oshio et al. Spermicidal activity of menfegol‐coated condom: Spermicide Aktivität eines Menfegol‐beschichteten Kondoms
Venere On research: new contraceptive gel prevents pregnancy and STDs
Lumbar 40 JOULY 6, 1963 ANY QUESTIONS? BRITISH MEDICAL JOURNAL
Forrester et al. Treatment of trichuris infection with albendazole

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20031222